Nextgen (NXGN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.111x

Based on the latest financial reports, Nextgen (NXGN) has a cash flow conversion efficiency ratio of 0.111x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.08 Million ≈ $-2.90K USD) by net assets (ILA-9.72 Million ≈ $-26.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Nextgen for the company's overall valuation and market capitalisation.

Nextgen - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Nextgen's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nextgen Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nextgen ranked by their cash flow conversion efficiency. See how well can Nextgen service its debt to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Uniinfo Telecom Services Limited
NSE:UNIINFO
0.029x
MUZHU MINING LTD
F:Y33
N/A
Invinity Energy Systems PLC
LSE:IES
-0.083x
Range International Ltd
AU:RAN
-0.672x
JZ Capital Partners Ltd
LSE:JZCP
0.125x
Real Messenger Corporation Ordinary Shares
NASDAQ:RMSG
-0.084x
MEP Infrastructure Developers Limited
NSE:MEP
-0.376x
Margaret Lake Diamonds Inc
V:DIA
0.054x

Annual Cash Flow Conversion Efficiency for Nextgen (2013–2024)

The table below shows the annual cash flow conversion efficiency of Nextgen from 2013 to 2024. View today's stock price for Nextgen for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA-2.46 Million
≈ $-6.61K
ILA-2.06 Million
≈ $-5.53K
0.837x -81.41%
2023-12-31 ILA-979.00K
≈ $-2.62K
ILA-4.41 Million
≈ $-11.81K
4.499x +2102.13%
2022-12-31 ILA12.25 Million
≈ $32.84K
ILA-2.75 Million
≈ $-7.38K
-0.225x -75.07%
2021-12-31 ILA20.71 Million
≈ $55.51K
ILA-2.66 Million
≈ $-7.13K
-0.128x +42.64%
2020-12-31 ILA6.87 Million
≈ $18.41K
ILA-1.54 Million
≈ $-4.12K
-0.224x +77.11%
2019-12-31 ILA1.17 Million
≈ $3.14K
ILA-1.15 Million
≈ $-3.07K
-0.978x -88.16%
2018-12-31 ILA2.39 Million
≈ $6.40K
ILA-1.24 Million
≈ $-3.33K
-0.520x -14.45%
2017-12-31 ILA3.66 Million
≈ $9.81K
ILA-1.66 Million
≈ $-4.45K
-0.454x -54.05%
2016-12-31 ILA5.13 Million
≈ $13.76K
ILA-1.51 Million
≈ $-4.06K
-0.295x +87.25%
2015-12-31 ILA1.74 Million
≈ $4.65K
ILA-4.01 Million
≈ $-10.76K
-2.312x -162.46%
2014-12-31 ILA-884.00K
≈ $-2.37K
ILA-3.27 Million
≈ $-8.77K
3.702x +205.08%
2013-12-31 ILA342.00K
≈ $916.89
ILA-1.21 Million
≈ $-3.23K
-3.523x --

About Nextgen

TA:NXGN Israel Medical Instruments & Supplies
Market Cap
$1.32 Million
ILA490.55 Million ILA
Market Cap Rank
#30507 Global
#446 in Israel
Share Price
ILA45.00
Change (1 day)
+17.19%
52-Week Range
ILA37.60 - ILA68.40
All Time High
ILA25020.00
About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.